← Eichor
Condition: Lower Grade Glioma Recurrent Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lower Grade Glioma Recurrent

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Phase 2 · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04267978Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
Phase 1 · 1 location(s) · Susan Chang · NCT04540107ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Phase 1 · 1 location(s) · Katy Peters, MD, PhD · NCT05609994
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.